Adelaide Research & Scholarship: Search

Search

Results 21-30 of 32 (Search time: 0.003 seconds).

previous
1
2
3
4
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2009	Development of a Disk Diffusion Method for Testing Moraxella catarrhalis Susceptibility Using Clinical and Laboratory Standards Institute Methods: a SENTRY Antimicrobial Surveillance Program Report	Bell, J.; Turnidge, J.; Jones, R.
	2013	Vancomycin AUC/MIC ratio and 30-Day mortality in patients with Staphylococcus aureus bacteremia	Holmes, N.; Turnidge, J.; Munckhof, W.; Robinson, J.; Korman, T.; O'Sullivan, M.; Anderson, T.; Roberts, S.; Warren, S.; Gao, W.; Howden, B.; Johnson, P.
	2001	In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia	Livermore, D.; Carter, M.; Bagel, S.; Wiedemann, B.; Baquero, F.; Loza, E.; Endtz, H.; van den Braak, N.; Fernandes, C.; Fernandes, L.; Frimodt-Moller, N.; Rasmussen, L.; Giamarellou, H.; Giamarellos-Bourboulis, E.; Jarlier, V.; Nguyen, J.; Nord, C.; Struelens, M.; Nonhoff, C.; Turnidge, J.; et al.
	2010	aac(6')-Ib-cr genotyping by simultaneous high-resolution melting analyses of an unlabeled probe and full-length amplicon	Bell, J.; Turnidge, J.; Andersson, P.
	2002	Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community	Okuma, K.; Iwakawa, K.; Turnidge, J.; Grubb, W.; Bell, J.; O'Brien, F.; Coombs, G.; Pearman, J.; Tenover, F.; Kapi, M.; Tiensasitorn, C.; Ito, T.; Hiramatsu, K.
	2010	Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models	Dudhani, R.; Turnidge, J.; Coulthard, K.; Milne, R.; Rayner, C.; Li, J.; Nation, R.
	2007	Statistical methods for establishing quality control ranges for antibacterial agents in clinical and laboratory standards institute susceptibility testing	Turnidge, J.; Bordash, G.
	2001	In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis	Li, J.; Turnidge, J.; Milne, R.; Nation, R.; Coulthard, K.
	2011	Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)	Espinel-Ingroff, A.; Cuenca-Estrella, M.; Fothergill, A.; Fuller, J.; Ghannoum, M.; Johnson, E.; Pelaez, T.; Pfaller, M.; Turnidge, J.
	2011	Quality Control Guidelines for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole Disk Diffusion Susceptibility Tests with Nonsupplemented Mueller-Hinton Agar (CLSI M51-A Document) for Nondermatophyte Filamentous Fungi	Espinel-Ingroff, A.; Canton, E.; Fothergill, A.; Ghannoum, M.; Johnson, E.; Jones, R.; Ostrosky-Zeichner, L.; Schell, W.; Gibbs, D.; Wang, A.; Turnidge, J.